Skip to main content

Werewolf Therapeutics, Inc.

HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001785530

In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Werewolf Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of HOWL: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders6973+4
Shares32.2M28.2M−4.03M (−12.5%)
Value$68.3M$41.7M−$26.6M (−38.9%)

New holders (12)

Institutions that held Werewolf Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to HOWL in Q4 2024
InstitutionSharesValue% of portfolio
Levin Capital Strategies, L.P.50,000$74.0K0.01%
Susquehanna International Group, LLP33,862$50.1K0.00%
D. E. Shaw & Co., Inc.17,776$26.3K0.00%
Intech Investment Management LLC14,866$22.0K0.00%
Two Sigma Securities, LLC12,740$18.9K0.00%
Larson Financial Group LLC10,000$14.8K0.00%
Advisor Group Holdings, Inc.8,575$12.7K0.00%
BNP Paribas Arbitrage, SA6,832$10.1K0.00%
Federated Hermes, Inc.414$6130.00%
SBI Securities Co., Ltd.40$590.00%
EverSource Wealth Advisors, LLC33$490.00%
IFP Advisors, Inc1$10.00%

Sold out (8)

Institutions that held Werewolf Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of HOWL in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Adage Capital Partners GP, L.L.C.2,000,594$4.24M
Eagle Health Investments LP700,000$1.48M
Point72 Asset Management, L.P.109,816$232.8K
Engineers Gate Manager LP11,777$25.0K
Citadel Advisors LLC11,507$24.4K
Point72 (DIFC) Ltd381$808
Russell Investments Group, Ltd.86$182
Capital Performance Advisors LLP60$127